A Patient Charter for Chronic Urticaria

被引:1
作者
Maurer, Marcus [1 ,2 ,3 ,4 ]
Albuquerque, Monica [5 ]
Boursiquot, Jean-Nicolas [6 ]
Dery, Elaine [7 ]
Gimenez-Arnau, Ana [8 ]
Godse, Kiran [9 ]
Guitierrez, Guillermo [10 ]
Kanani, Amin [11 ]
Lacuesta, Gina [12 ]
Mccarthy, Jessica [13 ]
Nigen, Simon [14 ]
Winders, Tonya [15 ]
机构
[1] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Fraunhofer Inst Translat Med & Pharmacol ITMP, Allergol & Immunol, Berlin, Germany
[5] Assoc Portuguesa Doentes Urticaria, Oeiras, Portugal
[6] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
[7] Canadian Chron Urticaria Soc, Quebec City, PQ, Canada
[8] Univ Pompeu Fabra, Hosp Mar, Res Inst, Barcelona, Spain
[9] Fortis Hiranandani Hosp, Mumbai, India
[10] FUNDAPSO, Cali, Colombia
[11] Univ British Columbia, Vancouver, BC, Canada
[12] Dalhousie Univ, Halifax, NS, Canada
[13] Novartis Pharmaceut, E Hanover, NJ USA
[14] McGill Univ, Montreal Gen Hosp, Montreal, PQ, Canada
[15] Global Allergy & Airways Patient Platform, Vienna, Austria
关键词
Angioedema; Chronic urticaria; Health care; Hives; Patient advocacy; Wheals; QUALITY-OF-LIFE; REAL-LIFE; NEEDS; MANAGEMENT; H-1-ANTIHISTAMINES; QUESTIONNAIRE; DEFINITION; OMALIZUMAB; DIAGNOSIS; BURDEN;
D O I
10.1007/s12325-023-02724-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic urticaria (CU) is the recurring development of wheals (aka "hives" or "welts"), angioedema, or both for more than 6 weeks. Wheals and angioedema occur with no definite triggers in chronic spontaneous urticaria, and in response to known and definite physical triggers in chronic inducible urticaria. Approximately 1.4% of individuals globally will have CU during their lifetime. The itching and physical discomfort associated with CU have a profound impact on daily activities, sexual function, work or school performance, and sleep, causing significant impairment in a patient's physical and mental quality of life. CU also places a financial burden on patients and healthcare systems. Patients should feel empowered to self-advocate to receive the best care. The voice of the patient in navigating the journey of CU diagnosis and management may improve patient-provider communication, thereby improving diagnosis and outcomes. A collaboration of patients, providers, advocacy organizations, and pharmaceutical representatives have created a patient charter to define the realistic and achievable principles of care that patients with CU should expect to receive. Principle (1): I deserve an accurate and timely diagnosis of my CU; Principle (2): I deserve access to specialty care for my CU; Principle (3): I deserve access to innovative treatments that reduce the burden of CU on my daily life; Principle (4): I deserve to be free of unnecessary treatment-related side-effects during the management of my CU; and Principle (5): I expect a holistic treatment approach to address all the components of my life impacted by CU. The stated principles may serve as a guide for healthcare providers who care for patients with CU and translate into better patient-physician communication. In addition, we urge policymakers and authors of CU treatment guidelines to consider these principles in their decision-making to ensure the goals of the patient are achievable.
引用
收藏
页码:14 / 33
页数:20
相关论文
共 79 条
  • [1] Development of the Cold Urticaria Activity Score
    Ahsan, Dalia Melina
    Altrichter, Sabine
    Gutsche, Annika
    Bernstein, Jonathan A.
    Altunergil, Tatjana
    Brockstaedt, Maxi
    Maurer, Marcus
    Weller, Karsten
    Terhorst-Molawi, Dorothea
    [J]. ALLERGY, 2022, 77 (08) : 2509 - 2519
  • [2] [Anonymous], 2022, CRUSE CHRONIC URTICA
  • [3] [Anonymous], 2023, URT DAY
  • [4] [Anonymous], 2023, MOXIE NONC US
  • [5] Automatic screening of self-evaluation apps for urticaria and angioedema shows a high unmet need
    Anto, Aram
    Maurer, Rasmus
    Gimenez-Arnau, Ana
    Cherrez-Ojeda, Ivan
    Hawro, Tomasz
    Magerl, Markus
    Metz, Martin
    Weller, Karsten
    Zuberbier, Torsten
    Bousquet, Jean
    Maurer, Marcus
    [J]. ALLERGY, 2021, 76 (12) : 3810 - 3813
  • [6] Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper
    Baiardini, I.
    Braido, F.
    Bindslev-Jensen, C.
    Bousquet, P. J.
    Brzoza, Z.
    Canonica, G. W.
    Compalati, E.
    Fiocchi, A.
    Fokkens, W.
    van Wijk, R. Gerth
    Gimenez-Arnau, A.
    Godse, K.
    Grattan, C.
    Grob, J. J.
    La Grutta, S.
    Kalogeromitros, D.
    Kocaturk, E.
    Lombardi, C.
    Mota-Pinto, A.
    Ridolo, E.
    Saini, S. S.
    Sanchez-Borges, M.
    Senna, G. E.
    Terreehorst, I.
    Bom, A. Todo
    Toubi, E.
    Bousquet, J.
    Zuberbier, T.
    Maurer, M.
    [J]. ALLERGY, 2011, 66 (07) : 840 - 844
  • [7] Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)
    Baiardini, Ilaria
    Fasola, Salvatore
    Maurer, Marcus
    Weller, Karsten
    Canonica, Giorgio Walter
    Braido, Fulvio
    [J]. ALLERGY, 2019, 74 (12) : 2542 - 2544
  • [8] The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries
    Balp, Maria-Magdalena
    Vietri, Jeffrey
    Tian, Haijun
    Isherwood, Gina
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (06) : 551 - 558
  • [9] Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria
    Bansal, Ciara Jade
    Bansal, Amolak Singh
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (01)
  • [10] The diagnosis and management of acute and chronic urticaria: 2014 update
    Bernstein, Jonathan A.
    Lang, David M.
    Khan, David A.
    Craig, Timothy
    Dreyfus, David
    Hsieh, Fred
    Sheikh, Javed
    Weldon, David
    Zuraw, Bruce
    Bernstein, David I.
    Blessing-Moore, Joann
    Cox, Linda
    Nicklas, Richard A.
    Oppenheimer, John
    Portnoy, Jay M.
    Randolph, Christopher R.
    Schuller, Diane E.
    Spector, Sheldon L.
    Tilles, Stephen A.
    Wallace, Dana
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (05) : 1270 - 1277